Analysis of awareness and acceptance of SARS-CoV-2 vaccination among pregnant women

Česká verzia

Authors: Jan Zapletal ; V. Drochýtek ; A. Vařbuchtová ; Michael Jiří Halaška ; Lukáš Rob
Authors place of work: Gynekologicko-porodnická klinika 3. LF UK a FN Královské Vinohrady, Praha
Published in the journal: Ceska Gynekol 2022; 87(2): 100-103
Category: Original Article
doi: https://doi.org/10.48095/cccg2022100

Summary

Vaccination is a widely discussed topic during pregnancy and breastfeeding. Due to newly emerging covid-19 variants, vaccination has become more and more important. These new variants pose a risk for the development of maternal and neonatal complications. The aim of this study was to conduct a survey among pregnant women to assess the awareness of covid-19 and vaccination. Among the respondents, 58% were vaccinated with at least one dose and 51% were fully vaccinated. Also, 77% percent of responders thought that there was an increased risk of severe covid-19 infection among pregnant women versus non-pregnant women, while 71% were aware of the risk of fetal death associated with covid-19 infection. Although the rate of awareness among pregnant women is quite high (up to 87%), it is crucial to present the advantages of vaccination among gynecologists and doctors of other specialties as they are able to motivate women to be vaccinated.

Keywords:

vaccination – COVID-19 – pregnancy – acceptance– awareness of pregnant women about covid-19

Zdroje

1. Magnus MC, Gjessing HK, Eide HN et al. Covid--19 vaccination during pregnancy and first-trimester miscarriage. N Engl J Med 2021; 385 (21): 2008–2010. doi: 10.1056/NEJMc2114466.

2. Peretz SB, Regev N, Novick L et al. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine. Ultrasound Obstet Gynecol 2021; 58 (3): 450–456. doi: 10.1002/uog.23729.

3. Allotey J, Stallings E, Bonet M et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370: m3320. doi: 10.1136/bmj.m3320.

4. Ko JY, DeSisto CL, Simeone RM et al. Adverse pregnancy outcomes, maternal complications, and severe illness among US delivery hospitalizations with and without a coronavirus disease 2019 (COVID-19) diagnosis. Clin Infect Dis 2021; 73 (Suppl 1): S24–S31. doi: 10.1093/cid/ciab 344.

5. DeSisto CL, Wallace B, Simeone RM et al. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization – United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (47): 1640–1645. doi: 10.15585/mmwr.mm7047e1.

6. Kasehagen L, Byers P, Taylor K et al. COVID-19- associated deaths after SARS-CoV-2infection during pregnancy – Mississippi, March 1, 2020-October 6, 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (47): 1646–1648. doi: 10.15585/ mmwr.mm7047e2.

7. Atyeo C, DeRiso EA, Davis C et al. COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women. Sci Transl Med 2021; 13 (617): eabi8631. doi: 10.1126/scitranslmed.abi8631.

8. Rottenstreich A, Zarbiv G, Oiknine-Djian E et al. Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study. Clin Microbiol Infect 2022; 28 (3): 419–425. doi: 10.1016/j.cmi.2021.10.003.

9. Rottenstreich A, Zarbiv G, Oiknine-Djian E et al. Efficient maternofetal transplacental transfer of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibodies after antenatal SARS-CoV-2 BNT162b2 messenger RNA vaccination. Clin Infect Dis 2021; 73 (10): 1909–1912. doi: 10.1093/cid/ciab 266.